Pharmafile Logo

Apodi Ltd

Established in 2006 by a group of highly experienced outsourcing business specialists, Apodi provides comprehensive outsourcing solutions to pharmaceutical and healthcare businesses and organisations. We recognise that the business environment for these industry sectors is changing and that there is a need for highly professional, tailored outsourcing services offering a rapid, effective response and delivering the best ROI. Through commercial insight, market intelligence and highly motivated people, Apodi helps our clients achieve improved outcomes and performance. Over the years we have worked hard to break the traditional model with a focus on the changing NHS environment and the challenge we all face to improve patient outcomes.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Company Details

One St Peters Road, Maidenhead, Berks, SL6 7QU, United Kingdom
+44 (0)1628 500 890

 Latest Content from PMHub 

DAM and CMS: managing assets to maximise adoption and value

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised...

Lucid launch new recruitment campaign to attract top talent in medical writing

We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

Knowing your audience is key to successful medical education

Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

How to enable each healthcare professional to fully understand your product

Read these three articles to understand how working at an individual level benefits all customers:

Alzheimer’s disease: reviewing the immediate treatment horizon

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.

A stumble, but not a fall – what’s next for Opdivo?

Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results.

Meet Anthill at conferences in London

October, the month of multichannel pharma marketing in London. Meet us at DigiPharm and Multichannel Excellence Summit

Immuno-oncology; bringing patients closer to treatment

What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment?

Therapy Watch market snapshots

Therapy Watch is a ‘real-time’ syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed,...